A
Aardvark Therapeutics Inc
NASDAQ:AARD
Aardvark Therapeutics Inc
NASDAQ:AARD
Price:
5.09
USD
-3.23%
Market Closed
Market Cap:
$110.8m
Cash Flow Statement
Cash Flow Statement
Aardvark Therapeutics Inc
Aardvark Therapeutics Inc
Currency: USD
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(21)
|
(30)
|
(37)
|
(49)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
0
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
3
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
2
|
|
| Change in Working Capital |
2
|
(1)
|
3
|
2
|
|
| Cash from Operating Activities |
(18)
N/A
|
(29)
-63%
|
(33)
-12%
|
(45)
-37%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(12)
|
(125)
|
(115)
|
(86)
|
|
| Cash from Investing Activities |
(12)
N/A
|
(125)
-939%
|
(115)
+8%
|
(86)
+25%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
85
|
177
|
92
|
92
|
|
| Other |
(3)
|
(6)
|
(4)
|
(4)
|
|
| Cash from Financing Activities |
82
N/A
|
171
+108%
|
88
-49%
|
88
+0%
|
|
| Change in Cash | |||||
| Net Change in Cash |
52
N/A
|
17
-68%
|
(60)
N/A
|
(43)
+29%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(18)
N/A
|
(30)
-63%
|
(33)
-12%
|
(45)
-37%
|
|
Switch to:
Switch to:
See Also
Discover More
